Literature DB >> 23549027

Gut microbial diversity is reduced and is associated with colonic inflammation in a piglet model of short bowel syndrome.

Susan Lapthorne1, Prue M Pereira-Fantini, Fiona Fouhy, Guineva Wilson, Sarah L Thomas, Nicole L Dellios, Michelle Scurr, Orla O'Sullivan, R Paul Ross, Catherine Stanton, Gerald F Fitzgerald, Paul D Cotter, Julie E Bines.   

Abstract

BACKGROUND AND OBJECTIVES: Following small bowel resection (SBR), the luminal environment is altered, which contributes to clinical manifestations of short bowel syndrome (SBS) including malabsorption, mucosal inflammation and bacterial overgrowth. However, the impact of SBR on the colon has not been well-defined. The aims of this study were to characterize the colonic microbiota following SBR and to assess the impact of SBR on mucosal inflammation in the colon.
RESULTS: Analysis of the colonic microbiota demonstrated that there was a significant level of dysbiosis both two and six weeks post-SBR, particularly in the phylum Firmicutes, coupled with a decrease in overall bacterial diversity in the colon. This decrease in diversity was associated with an increase in colonic inflammation six weeks post-surgery.
METHODS: Female (4-week old) piglets (5-6/group) received a 75% SBR, a transection (sham) or no surgery. Compositional analysis of the colonic microbiota was performed by high-throughput sequencing, two- and six-weeks post-surgery. The gene expression of the pro-inflammatory cytokines interleukin (IL)-1β, IL-6, IL-8, IL-18 and tumor necrosis factor (TNF)-α in the colonic mucosa was assessed by qRT-PCR and the number of macrophages and percentage inducible nitric oxide synthase (iNOS) staining in the colonic epithelium were quantified by immunohistochemistry.
CONCLUSIONS: SBR significantly decreased the diversity of the colonic microbiota and this was associated with an increase in colonic mucosal inflammation. This study supports the hypothesis that SBR has a significant impact on the colon and that this may play an important role in defining clinical outcome.

Entities:  

Keywords:  bacterial diversity; colonic microbiota; high-throughput sequencing; mucosal immunology; short bowel syndrome; small bowel resection

Mesh:

Year:  2013        PMID: 23549027      PMCID: PMC3669166          DOI: 10.4161/gmic.24372

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  46 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  The interaction between bacteria and bile.

Authors:  Máire Begley; Cormac G M Gahan; Colin Hill
Journal:  FEMS Microbiol Rev       Date:  2005-09       Impact factor: 16.408

Review 3.  Role of the colon in short bowel syndrome and intestinal transplantation.

Authors:  Olivier Goulet; Virginie Colomb-Jung; Francisca Joly
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-04       Impact factor: 2.839

4.  Differential intestinal M-cell gene expression response to gut commensals.

Authors:  Susan Lapthorne; John Macsharry; Paul Scully; Kenneth Nally; Fergus Shanahan
Journal:  Immunology       Date:  2012-07       Impact factor: 7.397

5.  Characterization of fecal microbial communities in patients with liver cirrhosis.

Authors:  Yanfei Chen; Fengling Yang; Haifeng Lu; Baohong Wang; Yunbo Chen; Dajiang Lei; Yuezhu Wang; Baoli Zhu; Lanjuan Li
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

6.  Very low birth weight preterm infants with surgical short bowel syndrome: incidence, morbidity and mortality, and growth outcomes at 18 to 22 months.

Authors:  Conrad R Cole; Nellie I Hansen; Rosemary D Higgins; Thomas R Ziegler; Barbara J Stoll
Journal:  Pediatrics       Date:  2008-09       Impact factor: 7.124

Review 7.  Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals.

Authors:  T T Kararli
Journal:  Biopharm Drug Dispos       Date:  1995-07       Impact factor: 1.627

8.  Noninvasive measurement of transit time in short bowel syndrome.

Authors:  Charlene Compher; Stephen Rubesin; Bruce Kinosian; Julie Madaras; David Metz
Journal:  JPEN J Parenter Enteral Nutr       Date:  2007 May-Jun       Impact factor: 4.016

Review 9.  Mortality and economics in short bowel syndrome.

Authors:  J Schalamon; J M Mayr; M E Höllwarth
Journal:  Best Pract Res Clin Gastroenterol       Date:  2003-12       Impact factor: 3.043

10.  The effect of feeding Bt MON810 maize to pigs for 110 days on intestinal microbiota.

Authors:  Stefan G Buzoianu; Maria C Walsh; Mary C Rea; Orla O'Sullivan; Fiona Crispie; Paul D Cotter; R Paul Ross; Gillian E Gardiner; Peadar G Lawlor
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

View more
  27 in total

1.  Small bowel resection induces long-term changes in the enteric microbiota of mice.

Authors:  J Sommovilla; Y Zhou; R C Sun; P M Choi; J Diaz-Miron; N Shaikh; E Sodergren; B B Warner; G M Weinstock; P I Tarr; B W Warner
Journal:  J Gastrointest Surg       Date:  2014-09-03       Impact factor: 3.452

2.  Severe Intestinal Dysbiosis in Rat Models of Short Bowel Syndrome with Ileocecal Resection.

Authors:  Yuhua Huang; Aoxue Chen; Feilong Guo; Jian Wang; Yousheng Li
Journal:  Dig Dis Sci       Date:  2019-08-22       Impact factor: 3.199

Review 3.  Mechanisms of intestinal adaptation.

Authors:  Deborah C Rubin; Marc S Levin
Journal:  Best Pract Res Clin Gastroenterol       Date:  2016-03-16       Impact factor: 3.043

4.  Is Serum Methylmalonic Acid a Reliable Biomarker of Vitamin B12 Status in Children with Short Bowel Syndrome: A Case Series.

Authors:  Lissette Jimenez; Danielle A Stamm; Brittany Depaula; Christopher P Duggan
Journal:  J Pediatr       Date:  2017-11-09       Impact factor: 4.406

5.  Changes in the colon microbiota and intestinal cytokine gene expression following minimal intestinal surgery.

Authors:  Susan Lapthorne; Julie E Bines; Fiona Fouhy; Nicole L Dellios; Guineva Wilson; Sarah L Thomas; Michelle Scurr; Catherine Stanton; Paul D Cotter; Prue M Pereira-Fantini
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

6.  Independence of gut bacterial content and neonatal necrotizing enterocolitis severity.

Authors:  Lauren K Barron; Barbara B Warner; Phillip I Tarr; William D Shannon; Elena Deych; Brad W Warner
Journal:  J Pediatr Surg       Date:  2017-04-05       Impact factor: 2.545

7.  Fecal microbiome and bile acid metabolome in adult short bowel syndrome.

Authors:  Harold J Boutte; Jacqueline Chen; Todd N Wylie; Kristine M Wylie; Yan Xie; Mackenzie Geisman; Anirudh Prabu; Vered Gazit; Phillip I Tarr; Marc S Levin; Brad W Warner; Nicholas O Davidson; Deborah C Rubin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-11-24       Impact factor: 4.052

8.  Remnant Small Bowel Length in Pediatric Short Bowel Syndrome and the Correlation with Intestinal Dysbiosis and Linear Growth.

Authors:  Holly J Engelstad; Lauren Barron; Joseph Moen; Todd N Wylie; Kristine Wylie; Deborah C Rubin; Nicholas Davidson; W Todd Cade; Barbara B Warner; Brad W Warner
Journal:  J Am Coll Surg       Date:  2018-08-02       Impact factor: 6.113

9.  The human milk oligosaccharide 2'-fucosyllactose augments the adaptive response to extensive intestinal.

Authors:  Ethan A Mezoff; Jennifer A Hawkins; Nicholas J Ollberding; Rebekah Karns; Ardythe L Morrow; Michael A Helmrath
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-12-23       Impact factor: 4.052

10.  Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis.

Authors:  Xiuting Hu; Wei Cheng; Shengxian Fan; Yuhua Huang; Xi Chen; Zhiwei Jiang; Jian Wang
Journal:  BMC Infect Dis       Date:  2021-06-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.